NCT00682136

Brief Summary

The aim of the study is to establish the efficacy of local anaesthetic TAP (transversus abdominis plane) blocks in providing pain relief in the first 24hrs following open or laparoscopic elective abdominal colorectal operations. TAP blocks involve the injection of local aesthetic (ropivicaine) into the transversus abdominis plane in the abdominal wall. This injection takes place after induction of anaesthesia, but before the commencement of surgery. TAP blocks have been proposed as a potential safer alternative to epidural anaesthesia. The blocks have been extensively used in the Hunter New England system over the last 18 months. As yet there is no clear evidence for there efficacy, hence the need for this trial. This trial would establish the efficacy of this practice. If the technique proves effective it could be widely used and provide a simpler method of managing post operative pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for phase_1 pain

Timeline
Completed

Started Apr 2008

Typical duration for phase_1 pain

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 22, 2008

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

June 3, 2010

Status Verified

June 1, 2010

Enrollment Period

1.7 years

First QC Date

May 20, 2008

Last Update Submit

June 2, 2010

Conditions

Keywords

postoperative analgesiaabdominal surgeryropivacainelocal anaesthesiatap blockpain management

Outcome Measures

Primary Outcomes (1)

  • mg/kg of morphine equivalent used by patients post operatively.

    From operation until discharge.

Secondary Outcomes (2)

  • Lung Function (spirometry), including FVC, FEV1 and PEFR

    24, 48 and 72 hours postoperatively

  • Visual Analogue Scale for pain at rest, deep breathing and coughing.

    24, 48 and 72 hours postoperatively

Study Arms (2)

1

ACTIVE COMPARATOR

Open Laparotomy Arm: All patients enrolled in the study who are undergoing elective open laparotomy surgery.

Procedure: US-Guided Ropivacaine TAP Block

2

ACTIVE COMPARATOR

Laparoscopic Arm: All patients enrolled in the study who are undergoing elective laparoscopic abdominal surgery.

Procedure: US-Guided Ropivacaine TAP Block

Interventions

Bilateral injection of local anaesthetic into the Transversus Abdominis plane, guided by ultrasound.

Also known as: TAP Block
12

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients aged 18 and over undergoing elective open or laparoscopic colorectal surgery performed by the participating surgeons within the study period will be considered for the trial.

You may not qualify if:

  • History of adverse reaction to Ropivicaine or similar drug.
  • Inability or refusal to give consent
  • Coagulopathic
  • Severe renal impairment
  • Aged \<18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

John Hunter Hospital

New Lambton, New South Wales, 2305, Australia

Location

Newcastle Private Hospital

New Lambton, New South Wales, 2305, Australia

Location

Private Medical Suites

New Lambton, New South Wales, 2305, Australia

Location

Mater Misericordiae Hospital

Waratah, New South Wales, 2298, Australia

Location

MeSH Terms

Conditions

PainAgnosia

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Brian Draganic, B.Med.,B.Med.Sci.(Hons),FRACS

    Hunter Colorectal Research

    PRINCIPAL INVESTIGATOR
  • Stephen Smith, B.Med.,F.R.A.C.S.

    Hunter Colorectal Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 20, 2008

First Posted

May 22, 2008

Study Start

April 1, 2008

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

June 3, 2010

Record last verified: 2010-06

Locations